In addition to PD-L1 IHC staining, all NSCLC tissue samples were sequenced using validated commercial multi-gene next-generation sequencing panels to explore the correlation between oncogenic mutations and PD-L1 expression. This evidence concerns the gene CD274 and non-small cell lung carcinoma.